scholarly journals Distinguishing parathyroid and thyroid lesions on ultrasound‐guided fine‐needle aspiration: A correlation of clinical data, ancillary studies, and molecular analysis

2017 ◽  
Vol 125 (9) ◽  
pp. 674-682 ◽  
Author(s):  
Margaret Cho ◽  
Thaira Oweity ◽  
Tamar C. Brandler ◽  
Karen Fried ◽  
Pascale Levine
Cytopathology ◽  
2018 ◽  
Vol 29 (6) ◽  
pp. 565-568 ◽  
Author(s):  
Helmi Khadra ◽  
Roostam Kholmatov ◽  
Dominique Monlezun ◽  
Emad Kandil

2019 ◽  
Vol 63 (1) ◽  
pp. 28-34
Author(s):  
Alexandra Kang ◽  
Alina Miranda ◽  
Bastiaan de Boer

Whilst cytological smears are still the basis of cytodiagnosis, there is an increasing role for ancillary testing. Specimens obtained are not always optimal, often with limited material for ancillary studies. Several reports have described the utility of scraping material from cytological smears to manufacture cell blocks to provide material for ancillary studies. Our objective was a retrospective review of the PathWest (QE2) experience with manufactured cell blocks (mCB) over the last 10 years. A total of 178 fine-needle aspiration cases with mCB were extracted from the PathWest database. Data were subdivided into: lymph node (89), breast (31), thyroid (23), soft tissue (13), liver (11), and other sites (11) and were analysed. All available material was reviewed. Diagnostic material was identified in 163 mCB (91.6%). Immunohistochemistry (IHC) was performed on 149 cases. Positive IHC staining was seen in 139 cases (93.3%) and advanced the diagnosis in 119 cases (79.9%). Molecular studies were performed on 38 mCB with adequate DNA obtained in 37 cases (97.3%). Our review has demonstrated that cellular material scraped from air-dried or prefixed smears can be made into cell blocks. Antigen preservation is adequate to provide diagnostically useful results with IHC whilst DNA integrity is preserved to allow molecular analysis.


CytoJournal ◽  
2016 ◽  
Vol 13 ◽  
pp. 1 ◽  
Author(s):  
Almed K. Alomari ◽  
Berrin Ustun ◽  
Harry R. Aslanian ◽  
Xinquan Ge ◽  
David Chhieng ◽  
...  

Background: Pancreatic masses may seldom represent a metastasis or secondary involvement by lymphoproliferative disorders. Recognition of this uncommon occurrence may help render an accurate diagnosis and avoid diagnostic pitfalls during endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). In this study, we review our experience in diagnosing secondary tumors involving the pancreas. Materials and Methods: The electronic database of cytopathology archives was searched for cases of secondary tumors involving the pancreas at our institution and a total of 31 cases were identified. The corresponding clinical presentations, imaging study findings, cytological diagnoses, the results of ancillary studies, and surgical follow-up, if available, were reviewed. Results: Nineteen of the patients were male and 12 female, with a mean age of 66 years. Twenty-three patients (74%) had a prior history of malignancy, with the latency ranging from 6 months to 19 years. The secondary tumors involving the pancreas included metastatic carcinoma (24 cases), metastatic sarcoma (3 cases), diffuse large B-cell lymphoma (2 cases), and plasma cell neoplasm (2 cases). The most common metastatic tumors were renal cell carcinoma (8 cases) and lung carcinoma (7 cases). Correct diagnoses were rendered in 29 cases (94%). The remaining two cases were misclassified as primary pancreatic carcinoma. In both cases, the patients had no known history of malignancy, and no ancillary studies were performed. Conclusions: Secondary tumors involving the pancreas can be accurately diagnosed by EUS-FNA. Recognizing uncommon cytomorphologic features, knowing prior history of malignancy, and performing ancillary studies are the keys to improve diagnostic performance and avoid diagnostic pitfalls.


Sign in / Sign up

Export Citation Format

Share Document